MANDEEP KAUR: Open Payments
NPI 1376213793 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 15 payments from 8 companies in 2025. Trend: 2023 $610 · 2024 $194 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $112 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: MOUNJARO, REXULTI, AUSTEDO XR, XIFAXAN, SPRAVATO, KISUNLA, ALVESCO, FARXIGA.
Industry payments across CA — which companies pay providers there.
